Health Care/Hospital
First Patient Dosed for MRCT Phase 3 Study on First-Line LS-SCLC of Henlius Anti-PD-1 mAb Serplulimab in Europe
SHANGHAI, Oct. 25, 2023 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the first patient inEurope has been dosed in the international multi-centre phase 3 clinical trial (NCT05353257) of the company's self-developed anti-PD-1 mAb HANSIZHUANG (serplulimab) in combination ...
2023-10-25 21:15
1962
Good Safety Profile and Antitumor Activity: Oral Presentation of Mabwell's 9MW2821 at 2023 ESMO
Shanghai, Oct. 25, 2023 /PRNewswire/ -- ESMO Congress 2023 was held in Madrid, Spain from October 20-24, the preliminary results of the Phase I/II study of 9MW2821 (Nectin-4 targeting ADC) in patients with advanced solid tumors were reported by Dr.Jian Zhang of Fudan University Shanghai Cancer Ce...
2023-10-25 17:46
1675
GC Cell Joins U.S Cancer Moonshot Project
Brining Expertise in NK Cell Therapy to Advance Efforts in Cancer Prevention, early detection, and treatment development ▶ New focus on NK cell therapy for conquering cancer ▶ GC Cell seizes the opportunity to share its cell gene therapy technology and capabilities globally ▶ Development of sol...
2023-10-25 11:27
1662
TidetronBioworks Illuminated in Global Spotlight at WFF 2023 for Sustainable Power
ROME, Oct. 24, 2023 /PRNewswire/ -- The World Food Forum (WFF) 2023, a global
platform dedicated to addressing the challenges ofSustainable Development Goals
2023-10-24 22:31
1479
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO
* Lunit SCOPE IO pivotal in first phase III trial successfully showing the efficacy of immunotherapy + chemotherapy for NSCLC patients with EGFR or ALK mutation - published in theJournal of Clinical Oncology and accepted by ESMO for oral presentation SEOUL, South Korea, Oct. 24, 2023 /PRNewswir...
2023-10-24 21:00
1614
Phase Ib/II Results of Akeso's PD-1/CTLA-4 Bispecific Antibody for First-Line Treatment of Advanced Hepatocellular Carcinoma Published at 2023 ESMO
HONG KONG, Oct. 24, 2023 /PRNewswire/ -- Akeso announced poster presentation at the 2023 European Society for Medical Oncology (ESMO) Congress from its cadonilimab ( PD-1/CTLA-4 bispecific antibody) combined with lenvatinib for first-line treatment of Advanced Hepatocellular Carcinoma (HCC). The ...
2023-10-24 20:00
1298
Clinical Trial Application (IND) for BioRay Pharmaceutical's BR105 Injection Receives U.S. FDA Approval
SHANGHAI, Oct. 24, 2023 /PRNewswire/ -- BioRay Pharmaceutical Co., Ltd. (hereinafter referred to as "BioRay") announced onOctober 7th that its clinical trial application for BR105 Injection has received approval from the United States Food and Drug Administration (FDA). This marks BioRay's first ...
2023-10-24 15:05
1235
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product
Visit OBiO at ESGCT 30th Annual Congress in Brussels SHANGHAI, Oct. 24, 2023 /PRNewswire/ -- OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract development and manufacturing organization for cell and gene therapy, officially announced an agreement with Refreshgene...
2023-10-24 12:05
1553
Wingderm® Has Unveiled the Latest Research of Mesoskin for Mesotherapy Treatment at AMWC
BEIJING, Oct. 23, 2023 /PRNewswire/ -- On October 20-22, 2023, the Aesthetic & Anti-Aging Medicine World Congress (AMWC) was held inChengdu, China. A wide range of aesthetic plastic surgery products and technologies made their appearance at this event, Wingderm®'s Latest Research of Mesoskin for ...
2023-10-24 09:23
1421
A Safer Tomorrow: AESOP Technology's Battle Against Look-Alike, Sound-Alike Medication Errors
SAN FRANCISCO, Oct. 23, 2023 /PRNewswire/ -- Medication errors are a critical
problem in healthcare, and Look-Alike, Sound-Alike (LASA) medication errors
pose a particularly daunting challenge. Studies
2023-10-24 00:03
1431
Genesis MedTech initiates enrollment in its North American Early Feasibility Study using the J-Valve™ Transfemoral System for patients with severe aortic regurgitation
BURLINGAME, Calif., Oct. 23, 2023 /PRNewswire/ -- Genesis MedTech, a leading medical device company, today announced initiation of enrollment in its North American Early Feasibility Study using its dedicated TAVR system, J-Valve™ Transfemoral (TF) System. The procedure was successfully perform...
2023-10-23 22:00
1764
Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis
MELBOURNE, Australia, Oct. 23, 2023 /PRNewswire/ -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation ...
2023-10-23 21:30
1409
WAT Medical Donates to the Canadian Red Cross and Peach Arch Hospital
VANCOUVER, BC, Oct. 23, 2023 /PRNewswire/ -- WAT Medical Enterprise Ltd. has
extended its support to two prominent institutions: the Canadian Red Cross and
Peach Arch Hospital, throughmonetary donations.
2023-10-23 21:00
1748
AI Diagnostic Platform Company Noul, unveils the result of Malaria study in Ethiopia and Ghana
* Reaffirming innovation as an AI-based digital microscope while presenting new malaria data at the annual meeting of the ASTMH 2023 * Noul's 'miLab™' showed significantly higher sensitivity than that of microscopy in health centers YONGIN, South Korea, Oct. 23, 2023 /PRNewswire/ -- Noul Co.,...
2023-10-23 21:00
1761
COSMAX NBT Showcases Exclusive Materials and Formulations at SSW 2023, Strengthening its Presence in the U.S. Market
* Display microemulsion technology and plant-based formulation * Various exclusive materials prepared for skin health, wrinkles, and even hair health SEONGNAM, South Korea, Oct. 23, 2023 /PRNewswire/ -- COSMAX NBT, a global leading supplements ODM (original development manufacturing) company, ...
2023-10-23 21:00
1883
VUNO Secures FDA 510(k) Clearance for VUNO Med®-DeepBrain®
SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- VUNO Inc., South Korean
medical AI company has received 510(k) clearance from the Food and Drug
Administration (FDA) for its AI-powered brain quantification device, VUNO
Med®-DeepBrain®.
2023-10-23 21:00
1964
Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day
SHANGHAI, Oct. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that its Zhongxin platform launched a WeChat mini program of Bre...
2023-10-23 20:00
1369
Live from ESMO 2023 | Oral Report Featuring Latest Data of Pelcitoclax (APG-1252) Combined with Osimertinib Demonstrates Potential as a New Treatment Option for TP53-and EGFR-Mutant NSCLC
SUZHOU, China and ROCKVILLE, Md., Oct. 23, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released the latest clinical data of it...
2023-10-23 19:56
1309
Mabwell Announces Latest Clinical Progress and Data to be Reported on ESMO 2023 of 2 Novel Drugs
SHANGHAI, Oct. 23, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announces the latest clinical progress of 2 novel drugs including Nectin-4 ADC 9MW2821, as well as the clinical study data to be reported on ESMO 2023. Latest progress...
2023-10-23 18:25
1422
JINGHAO MEDICAL's self-fitting OTC hearing aids received FDA 510(k) approval
HONGKONG, SHANGHAI, and BEIJING, Oct. 23, 2023 /PRNewswire/ -- As the first hearing aid manufacturer to be listed in China, JINGHAO MEDICAL has once again taken a historic step. OnSeptember 26, 2023, the self-fitting OTC hearing aid developed and manufactured by JINGHAO MEDICAL officially receive...
2023-10-23 18:01
1331
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6801
